Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PEACE V: a Randomized Phase II Trial for the Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)

NCT03569241 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT03569241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03569241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PEACE V: a Randomized Phase II Trial for the Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (STORM)
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 27, 2018
Completion date
December 31, 2026
Enrollment
196 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, oligometastatic cancer, prostate cancer, prostate cancer metastatic